1. Tract-specific spinal damage in SCA2, SCA3 and SCA6.
- Author
-
de Borba FC, Fernandes JMS, de Rezende TJR, González-Salazar C, de Melo Teixeira Branco L, Wolmer PS, Pedroso JL, Barsottini OGP, and França Junior MC
- Subjects
- Humans, Male, Female, Middle Aged, Adult, Aged, Magnetic Resonance Imaging, Spinal Cord diagnostic imaging, Spinal Cord pathology, White Matter diagnostic imaging, White Matter pathology, Atrophy pathology, Machado-Joseph Disease diagnostic imaging, Machado-Joseph Disease pathology, Diffusion Tensor Imaging, Ataxin-2, Spinocerebellar Ataxias diagnostic imaging, Spinocerebellar Ataxias pathology
- Abstract
Background: Spinocerebellar ataxias (SCAs) are a group of neurodegenerative disorders characterized by progressive ataxia. Although previous studies have focused on cerebral and cerebellar damage, spinal cord involvement in SCAs remains underexplored., Objectives: This study aims to characterize spinal cord abnormalities in SCA2, SCA3, and SCA6 and to identify its phenotypic correlates., Methods: We conducted a multimodal spinal neuroimaging study on 26 SCA3, 16 SCA2, and 14 SCA6 patients, along with matched healthy controls. MRI scanning was performed using a 3 Tesla device, and the Spinal Cord Toolbox (SCT) was employed for morphometric and diffusivity analyses of the cervical spinal cord., Results: Our findings revealed significant spinal cord atrophy and altered white matter microstructural metrics in SCA3 and SCA2 patients compared to controls, with no abnormalities in SCA6. A strong negative correlation was observed between cross-sectional cord area and disease duration in SCA2, suggesting its potential as a biomarker for disease progression., Conclusions: This study highlights the importance of spinal cord imaging in understanding the pathophysiology of SCAs and demonstrates the utility of MRI-based metrics in identifying structural deviations and their clinical correlates. Further longitudinal studies are needed to validate these findings and explore their implications for clinical trials and therapeutic interventions., Competing Interests: Declarations. Conflicts of interest: The authors declare no conflits of interest. Ethical approval: Ethics Committee of Clinics Hospital at University of Campinas approved the study protocol (registered as “CAAE 29869520.8.3001.5404”). The Study was performed compliant to the Declaration of Helsinki., (© 2024. Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF